Chinmoy Sankar Dey

[2] Afterwards, he joined the Indian Institute of Chemical Biology, in Kolkata, as a research fellow for his doctoral studies and submitted his thesis Biochemical regulation of sperm motility, which earned him a PhD from Jadavpur University in 1990.

On his return to India in 1992, he started his career by joining the National Institute of Immunology as a pool officer, but his stay there lasted only for two years.

In 1994, he moved to National Institute of Pharmaceutical Education and Research, Mohali as an assistant professor at the department of biotechnology where he served for over a decade and a half.

In 2010, he moved his base to New Delhi to join the Indian Institute of Technology at Kusuma School of Biological Sciences as a professor[4][5] and is the head of the Central Research Facility.

[12] His team identified for the first time the apoptosis-like cell death in Type II topoisomerase and suggested the enzyme as a possible treatment protocol for Leishmaniasis.

[13] He also proposed eIF4A, a member of a set of three related proteins, as a drug target to combat infection with Leishmania donovani, a Miltefosine-resistant type of trypanosome causing leishmaniasis.

[18][19][20] James Watson, a recipient of the Nobel Prize in Physiology or Medicine in 1962, cited one of Dey's papers in his 2013 lecture at University of California, Los Angeles to commemorate the 60th anniversary of the discovery of double helical structure DNA,[1] which was later published as an article in Lancet in 2014.